1. Next-Generation Sequencing Gene Panels and 'Solo' Clinical Exome Sequencing Applied in Structurally Abnormal Fetuses
- Author
-
Pauta M, Campos B, Segura-Puimedon M, Arca-Diaz G, Nadal A, Tubau A, Perez SP, Marimon-Garcia E, Martín L, López-Quesada E, Sabria-Bach J, Muñoz B, Garcia E, Paz Y Miño F, Borobio V, Gomez O, Eixarch E, Lopez M, Comas Rovira M, Borrell A, and Borrell, Antoni
- Subjects
Congenital malformations ,Exome sequencing ,Fetal genetic analysis ,Prenatal diagnosis ,Genetic disorder ,Single gene disorders - Abstract
OBJECTIVE: The aim of the study was to assess the diagnostic yield of 2 different next-generation sequencing (NGS) approaches: gene panel and "solo" clinical exome sequencing (solo-CES), in fetuses with structural anomalies and normal chromosomal microarray analysis (CMA), in the absence of a known familial mutation. METHODOLOGY: Gene panels encompassing from 2 to 140 genes, were applied mainly in persistent nuchal fold/fetal hydrops and in large hyperechogenic kidneys. Solo-CES, which entails sequencing the fetus alone and only interpreting the Online Mendelian Inheritance in Man genes, was performed in multisystem or recurrent structural anomalies. RESULTS: During the study period (2015-2020), 153 NGS studies were performed in 148 structurally abnormal fetuses with a normal CMA. The overall diagnostic yield accounted for 35% (53/153) of samples and 36% (53/148) of the fetuses. Diagnostic yield with the gene panels was 31% (15/49), similar to 37% (38/104) in solo-CES. CONCLUSIONS: A monogenic disease was established as the underlying cause in 35% of selected fetal structural anomalies by gene panels and solo-CES.
- Published
- 2021